Literature DB >> 2351132

Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms.

D H Wreschner1, M Hareuveni, I Tsarfaty, N Smorodinsky, J Horev, J Zaretsky, P Kotkes, M Weiss, R Lathe, A Dion.   

Abstract

The isolation and characterization of complementary DNAs (cDNAs) which code for an epithelial antigen aberrantly expressed in human breast tumor tissue are described here. The only information regarding the primary structure of this potentially important antigen has been a 20-amino-acid repeat motif. We now report the complete amino acid sequences of different forms of the human epithelial tumor antigen as deduced from the nucleotide sequence of isolated non-repeat cDNAs. The diversity of protein forms is generated by a series of alternative splicing events that occur in the regions located upstream and downstream to a central tandem repeat array. Isolated cDNAs coding for the upstream region show that differential usage of alternative splice acceptor sites may generate two protein forms containing putative signal peptides of varying hydrophobicities. The complexity of possible antigen forms is further compounded by alternative splicing events occurring in the region 3' to the repeat array. The isolated cDNAs 3' to the tandem repeats indicate that whereas one mRNA transcript is colinear with the gene, and defines an open reading frame (ORF) containing 160 amino acids downstream to the repeat array, a second cDNA correlates with a mRNA that is generated by a series of splicing events. The deduced amino acid sequence of the spliced cDNA contains an ORF that is identical for 149 amino acids downstream to the repeat array with the amino acid sequence of the unspliced cDNA. At this point it diverges and continues for an additional 179 amino acids. The sequence contains a highly hydrophobic 28-amino-acid peptide, located towards the carboxyl terminus, that may correspond to a transmembrane region. The cDNAs and deduced amino acid sequences, presented here, define the complete amino acid sequences of the epithelial tumor antigen and demonstrate the existence of multiple protein forms that probably localize to different cellular and extracellular compartments.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351132     DOI: 10.1111/j.1432-1033.1990.tb15511.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  52 in total

1.  Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins.

Authors:  Daniel H Wreschner; Michael A McGuckin; Stefanie J Williams; Amos Baruch; Merav Yoeli; Ravit Ziv; Liron Okun; Joseph Zaretsky; Nechama Smorodinsky; Iafa Keydar; Pavlos Neophytou; Martin Stacey; His-Hsien Lin; Siamon Gordon
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  Expression of the human MUC1 mucin cDNA in a hamster pancreatic tumor cell line HP-1.

Authors:  S K Batra; R S Metzgar; A J Worlock; M A Hollingsworth
Journal:  Int J Pancreatol       Date:  1992-12

3.  Selection of peptide ligands for the antimucin core antibody C595 using phage display technology: definition of candidate epitopes for a cancer vaccine.

Authors:  P Laing; P Tighe; E Kwiatkowski; J Milligan; M Price; H Sewell
Journal:  Clin Mol Pathol       Date:  1995-06

4.  MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism.

Authors:  N W Toribara; J R Gum; P J Culhane; R E Lagace; J W Hicks; G M Petersen; Y S Kim
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 5.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

6.  Molecular cloning of a major human gall bladder mucin: complete C-terminal sequence and genomic organization of MUC5B.

Authors:  A C Keates; D P Nunes; N H Afdhal; R F Troxler; G D Offner
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

7.  Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

Authors:  V Apostolopoulos; G A Pietersz; B E Loveland; M S Sandrin; I F McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Bovine gall-bladder mucin contains two distinct tandem repeating sequences: evidence for scavenger receptor cysteine-rich repeats.

Authors:  D P Nunes; A C Keates; N H Afdhal; G D Offner
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

Review 9.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

10.  Effects of VIP on the regulation of mucin secretion in cultured human pancreatic cancer cells (Capan-1).

Authors:  E Hollande; M Fanjul; S Claret; M E Forgue-Lafitte; J Bara
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.